MS Speaks

Multiple Sclerosis => TREATMENTS => COPAXONE, GLATOPA (glatiramer acetate) => Topic started by: agate on March 08, 2019, 09:39:32 pm

Title: US FDA declines to approve GA Depot (yet)
Post by: agate on March 12, 2024, 09:58:17 am

The US FDA has declined to approve GA Depot. Apparently more information is needed, and this may be just a matter of a delay.


From Neurology Live (March 22, 2024)--"FDA Issues Complete Response Letter for Long-Acting Form of Glatiramer Acetate for Relapsing Multiple Sclerosis":


https://bit.ly/48QUXIA

Title: Use of GA depot for progressive MS given US patent
Post by: agate on June 23, 2022, 09:11:19 pm

The injection, given every 4 weeks, is intramuscular. The main justification for bringing this new type of glatiramer acetate onto the market seems to be that it would be more convenient for people, and so patient compliance would be improved.

From Multiple Sclerosis News Today (April 2, 2022)--"Use of GA Depot in Treating Progressive MS Given US Patent":


https://multiplesclerosisnewstoday.com/news-posts/2022/04/1/ga-depot-mapi-pharma-given-us-patent-treatment-progressive-ms/

Title: Re: Long-acting glatiramer acetate (GA Depot) for RRMS and PPMS announced
Post by: agate on March 25, 2019, 07:26:33 am

The drug companies usually seem to charge whatever price the market will bear--and the sky may be the limit.

Title: Re: Long-acting glatiramer acetate (GA Depot) for RRMS and PPMS announced
Post by: ewizabeth on March 25, 2019, 07:10:40 am

I bet that will be expensive compared to the injections.

Title: Long-acting glatiramer acetate (GA Depot) for RRMS and PPMS announced
Post by: agate on March 08, 2019, 09:39:32 pm

This new MS drug, to be marketed for RRMS and PPMS, seems to be a "depot" version of glatiramer acetate (Copaxone), injected every 4 weeks. Just when it will become available isn't clear:


http://www.globenewswire.com/news-release/2019/02/21/1739488/0/en/Mapi-Pharma-to-Host-Key-Opinion-Leader-Meeting-on-Long-Acting-Glatiramer-Acetate-GA-Depot-for-Primary-Progressive-Multiple-Sclerosis-and-New-Treatments-for-MS.html